- $3.02bn
- $6.02bn
- $4.00bn
- 78
- 92
- 85
- 98
Annual income statement for VEON, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 6-K |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 7,291 | 3,850 | 3,755 | 3,698 | 4,004 |
| Cost of Revenue | |||||
| Gross Profit | 5,579 | 3,366 | 3,279 | 3,257 | 3,489 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 6,780 | 2,827 | 2,592 | 2,817 | 2,894 |
| Operating Profit | 511 | 1,023 | 1,163 | 881 | 1,110 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -82 | 464 | 802 | 559 | 704 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -395 | 120 | 733 | 380 | 487 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -349 | 674 | -162 | -2,528 | 415 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -349 | 674 | -162 | -2,528 | 414 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.089 | 0.003 | 0.23 | 0.17 | 0.172 |